Chaoyuan Kuang

Assistant Professor

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Chaoyuan Kuang is an Assistant Professor at the Albert Einstein Cancer Center in the United States. His research focuses on gastrointestinal malignancies, with a particular emphasis on targeting angiogenesis, the tumor microenvironment, and advancements in therapies for colorectal cancer. Dr. Kuang's recent publications explore topics such as immunotherapy efficacy, KRAS mutations, and overcoming resistance in cancer treatment.

Articles (9)

Year:

2025

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2020

Year:

2020

Year:

University of Pittsburgh

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Chaoyuan Kuang

Research Interests

Explore related searches

Contact this professor

About

Articles (9)

Emerging Strategies for Targeting Angiogenesis and the Tumor Microenvironment in Gastrointestinal Malignancies: A Comprehensive Review

An Evolving Landscape: New Therapies for Metastatic Colorectal Cancer

Targeting KRAS in Colorectal Cancer: A Bench to Bedside Review

Targeting Myc-driven stress vulnerability in mutant KRAS colorectal cancer

Pembrolizumab plus azacitidine in patients with chemotherapy refractory metastatic colorectal cancer: a single-arm phase 2 trial and correlative biomarker analysis

Immunotherapy efficacy on mismatch repair-deficient colorectal cancer: From bench to bedside.

Mcl-1 inhibition overcomes intrinsic and acquired regorafenib resistance in colorectal cancer.

A rare case of MGRS with immunotactoid glomerulopathy responding to bortezomib, dexamethasone, and rituximab

Biomarker analysis for UPCI 14-118: Phase II study of pembrolizumab in combination with azacitidine in patients with refractory metastatic colorectal cancer.

Collaborators (5)

Jian Yu

Fernand Bteich

Yi Huang

NING WEI

Lin Zhang

Make your next move.